Literature DB >> 15639648

Exogenous leptin restores in vitro T cell proliferation and cytokine synthesis in patients with common variable immunodeficiency syndrome.

Anna Carla Goldberg1, Freddy Goldberg Eliaschewitz, Wagner Ricardo Montor, Gisele Vanessa Baracho, Paolo Ruggero Errante, Mariana Alejandra Callero, Maria Regina Alves Cardoso, Patricia Emilia Braga, Jorge Kalil, Mari Cleide Sogayar, Luiz Vicente Rizzo.   

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia. Leptin has been implicated as an antiapoptotic compound as well as a stimulant of the immune response. Leptin administration is capable of reversing the immune deficiency that occurs upon starvation. We investigated a possible role for leptin in CVID; a condition associated with lowered plasma leptin levels. Thirty-eight patients were studied. Addition of leptin to the tissue culture media of PBMC from CVID patients increased the proliferative response of lymphocytes to mitogens and decreased activation-induced apoptosis of these cells. IL-2 and specially IL-4 production also increased significantly upon addition of leptin to the PBMC cultures. Our results suggest that leptin may be involved in some of the cellular defects observed in CVID and indicate a novel therapeutic strategy to improve immune function in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639648     DOI: 10.1016/j.clim.2004.09.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes.

Authors:  Yngvar Gundersen; Per Kristian Opstad; Trine Reistad; Ingjerd Thrane; Per Vaagenes
Journal:  Eur J Appl Physiol       Date:  2006-02-28       Impact factor: 3.078

2.  Pharmacogenetic contribution of leptin gene polymorphism in cutaneous T-cell lymphoma.

Authors:  Vladimir Vasku; Anna Vasku; Julie Bienertova Vasku
Journal:  Int J Clin Exp Pathol       Date:  2008-07-18

Review 3.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

4.  Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation.

Authors:  A Johnston; S Arnadottir; J E Gudjonsson; A Aphale; A A Sigmarsdottir; S I Gunnarsson; J T Steinsson; J T Elder; H Valdimarsson
Journal:  Br J Dermatol       Date:  2008-06-28       Impact factor: 9.302

5.  Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration.

Authors:  Hyun-Seuk Moon; Joo Young Huh; Fadime Dincer; Benjamin E Schneider; Per-Olof Hasselgren; Christos S Mantzoros
Journal:  Diabetes       Date:  2014-09-23       Impact factor: 9.461

Review 6.  T-cell abnormalities in common variable immunodeficiency: the hidden defect.

Authors:  Gabriel K Wong; Aarnoud P Huissoon
Journal:  J Clin Pathol       Date:  2016-05-06       Impact factor: 3.411

7.  Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy.

Authors:  Antonio Pecoraro; Ersilia Nigro; Rita Polito; Maria Ludovica Monaco; Olga Scudiero; Ilaria Mormile; Azzurra Cesoni Marcelli; Mario Capasso; Francesco Habetswallner; Arturo Genovese; Aurora Daniele; Giuseppe Spadaro
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

8.  Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy.

Authors:  Rita Polito; Ersilia Nigro; Antonio Pecoraro; Maria Ludovica Monaco; Franco Perna; Alessandro Sanduzzi; Arturo Genovese; Giuseppe Spadaro; Aurora Daniele
Journal:  Front Immunol       Date:  2019-11-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.